<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-0099</journal-id>
<journal-title><![CDATA[Cirujano general]]></journal-title>
<abbrev-journal-title><![CDATA[Cir. gen]]></abbrev-journal-title>
<issn>1405-0099</issn>
<publisher>
<publisher-name><![CDATA[Asociación Mexicana de Cirugía General A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-00992014000300145</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de linfedema en extremidades superiores secundario a mastectomía por cáncer]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence of upper extremity lymphedema after mastectomy for breast cancer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gutiérrez Pérez]]></surname>
<given-names><![CDATA[Erick E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Avalos Nuño]]></surname>
<given-names><![CDATA[Joel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salas González]]></surname>
<given-names><![CDATA[Efraín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Montes Velázquez]]></surname>
<given-names><![CDATA[Leonora]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guzman Pantoja]]></surname>
<given-names><![CDATA[Jaime E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pánuco Ayala]]></surname>
<given-names><![CDATA[Perla G.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Departamento de Oncología Ginecológica ]]></institution>
<addr-line><![CDATA[Guadalajara Jalisco]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Departamento de Epidemiología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2014</year>
</pub-date>
<volume>36</volume>
<numero>3</numero>
<fpage>145</fpage>
<lpage>149</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-00992014000300145&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-00992014000300145&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-00992014000300145&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Introducción: El linfedema posmastectomía es una complicación que surge luego de una intervención quirúrgica por cáncer de mama. Su incidencia varía en función de diversos aspectos, como la técnica quirúrgica utilizada, la zona anatómica afectada y que se utilice radioterapia o no, entre otros. Se presenta como tumefacción indolora de la extremidad afectada en su parte distal que progresa proximalmente por ella. El objetivo del estudio es mostrar la prevalencia de linfedema en extremidades superiores secundario a mastectomía en pacientes con cáncer mamario. Material y métodos: Se realizó un estudio transversal descriptivo. Se procedió a identifi car todos los registros de expedientes de pacientes intervenidas. Se incluyó a 334 pacientes. Las variables estudiadas son edad, presencia de linfedema en extremidad superior, clasifi cación del estadio del linfedema, mecanismo de producción del linfedema, tiempo después de la intervención y manejo. Resultados: De las 334 pacientes, se presentó linfedema en el 32.63% del total. De estos, en 54 casos (57.4%) el linfedema fue de grado 2. De las 98 pacientes sometidas a cirugía conservadora, solo 7 tenían linfedema de grado 1.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Introduction: Post-mastectomy lymphedema is a complication after surgery due to breast cancer. The incidence varies depending on several aspects, including the surgical technique used, the anatomical area affected, and the use of radiotherapy. It is presented as painless swelling of the affected limb in its distal part that progress proximally. The objective of the study is to determine the prevalence of upper extremity lymphedema secondary to mastectomy in patients with breast cancer. Material and Methods: A descriptive cross-sectional study was performed in which all records of patient who underwent a surgery were reviewed. A total of 334 patients were included. The variables studied were age, presence of upper limb lymphedema, lymphedema stage classifi cation, mechanism of lymphedema, time after intervention, and management. Results: Of the 334 patients, lymphedema occurred in 32.63% of the total. Of these, 54 cases (57.4%) were grade 2 lymphedema. Among the 98 patients undergoing conservative surgery, only 7 showed grade 1 lymphedema. Conclusion: The prevalence of lymphedema, is similar to the results of others worldwide studies, with about 30 percent for those with mastectomy and less than 10 percent for those who underwent conservative surgery, and a higher rate of lymphedema for those who underwent radical surgery.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Linfedema posmastectomía]]></kwd>
<kwd lng="es"><![CDATA[Cáncer de mama]]></kwd>
<kwd lng="en"><![CDATA[Postmastectomy lymphedema]]></kwd>
<kwd lng="en"><![CDATA[Breast cancer]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>American Cancer Society</collab>
<source><![CDATA[Breast cancer facts and figures 2005-2006]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Di saia]]></surname>
<given-names><![CDATA[Creasman]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical gynecologyc oncology]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Breast cancer screening]]></source>
<year>2007</year>
<page-range>534-78</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clodius]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Piller]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The conservatic treatment of postmastectomy lymphoedema patients with cournarin results in a market continuous reduction in arm swelling. En advances u lymphology]]></article-title>
<source><![CDATA[Avicenum Czechos lovak Medical press]]></source>
<year>2011</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
